MetLife Investment Management’s Paysign PAYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,444
Closed -$58.9K 2824
2025
Q4
$58.9K Sell
11,444
-8,332
-42% -$44.9K ﹤0.01% 2714
2025
Q3
$124K Sell
19,776
-1,343
-6% -$8.59K ﹤0.01% 2555
2025
Q2
$152K Buy
+21,119
New +$75.6K ﹤0.01% 2331
2024
Q4
Sell
-3,515
Closed -$12.9K 2843
2024
Q3
$12.9K Sell
3,515
-15,412
-81% -$70.2K ﹤0.01% 2834
2024
Q2
$81.6K Buy
+18,927
New +$83.5K ﹤0.01% 2678
2020
Q3
Sell
-15,230
Closed -$148K 2325
2020
Q2
$148K Buy
+15,230
New +$112K ﹤0.01% 2063
2020
Q1
Sell
-14,584
Closed -$148K 2281
2019
Q4
$148K Buy
14,584
+6,043
+71% +$63.5K ﹤0.01% 2138
2019
Q3
$86.3K Sell
8,541
-9,210
-52% -$123K ﹤0.01% 2317
2019
Q2
$237K Buy
+17,751
New +$169K ﹤0.01% 1928

Other funds holding PAYS

MetLife Investment Management's PAYS Position: Q1 2026 in Review

MetLife Investment Management sold out of Paysign (PAYS) in Q1 2026, closing a stake of 11,444 shares — an estimated $58.9K sold.

MetLife Investment Management first reported a position in PAYS in Q2 2019 and held it in 9 quarters. The position peaked at $237K in Q2 2019. 111 funds tracked by Wall St. Rank hold PAYS as of Q1 2026.

  • MetLife Investment Management reported no remaining Paysign position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 11,444 Paysign shares in Q1 2026, an estimated $58.9K.
  • MetLife Investment Management first reported a position in Paysign in Q2 2019 and held it in 9 quarters.
  • MetLife Investment Management's Paysign position peaked at $237K in Q2 2019.
  • 111 funds tracked by Wall St. Rank held Paysign as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.